Michael Petusky
Stock Analyst at Barrington Research
(2.21)
# 2,738
Out of 5,182 analysts
241
Total ratings
39.27%
Success rate
-3.23%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Outperform | $42 → $32 | $21.14 | +51.37% | 20 | May 1, 2026 | |
| LFCR Lifecore Biomedical | Maintains: Outperform | $5.5 → $6 | $5.13 | +16.96% | 10 | Apr 29, 2026 | |
| OPK OPKO Health | Downgrades: Market Perform | n/a | $1.11 | - | 17 | Apr 29, 2026 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $109 → $107 | $62.01 | +72.55% | 27 | Apr 20, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $17 | $12.00 | +41.67% | 7 | Apr 10, 2026 | |
| BVS Bioventus | Maintains: Outperform | $13 → $14 | $10.17 | +37.66% | 2 | Mar 6, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 → $17 | $11.20 | +51.79% | 28 | Mar 2, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $14.58 | +16.60% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $111.53 | -5.85% | 15 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $72.02 | +34.68% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 | $70.92 | +45.23% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $94 | $55.32 | +69.92% | 36 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1 → $1.5 | $0.79 | +89.63% | 11 | Jan 6, 2026 |
Option Care Health
May 1, 2026
Maintains: Outperform
Price Target: $42 → $32
Current: $21.14
Upside: +51.37%
Lifecore Biomedical
Apr 29, 2026
Maintains: Outperform
Price Target: $5.5 → $6
Current: $5.13
Upside: +16.96%
OPKO Health
Apr 29, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $1.11
Upside: -
Merit Medical Systems
Apr 20, 2026
Maintains: Outperform
Price Target: $109 → $107
Current: $62.01
Upside: +72.55%
Orthofix Medical
Apr 10, 2026
Maintains: Outperform
Price Target: $17
Current: $12.00
Upside: +41.67%
Bioventus
Mar 6, 2026
Maintains: Outperform
Price Target: $13 → $14
Current: $10.17
Upside: +37.66%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14 → $17
Current: $11.20
Upside: +51.79%
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $14.58
Upside: +16.60%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $111.53
Upside: -5.85%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $72.02
Upside: +34.68%
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $70.92
Upside: +45.23%
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $55.32
Upside: +69.92%
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.79
Upside: +89.63%